These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 116791)

  • 1. Non-parenteral combined afterload and preload reduction therapy in congestive heart failure.
    Mehta J; Pepine CJ; Conti CR
    Clin Cardiol; 1978 Aug; 1(2):68-73. PubMed ID: 116791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of hydrallazine and of hydrallazine plus glyceryl trinitrate paste in heart failure.
    Mehta J; Pepine CJ; Conti CR
    Br Heart J; 1978 Aug; 40(8):845-50. PubMed ID: 99155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hemodynamic effects of chewable isosorbide dinitrate and nitroglycerin in patients with congestive heart failure.
    Mikulic E; Franciosa JA; Cohn JN
    Circulation; 1975 Sep; 52(3):477-82. PubMed ID: 808359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure. Differential effects of hydralazine, enalaprilat, and nitroglycerin.
    Wang SY; Manyari DE; Scott-Douglas N; Smiseth OA; Smith ER; Tyberg JV
    Circulation; 1995 Feb; 91(4):1205-12. PubMed ID: 7850960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
    Haitas B; Meyer TE; Angel ME; Reef E
    Br J Clin Pharmacol; 1990 Mar; 29(3):366-8. PubMed ID: 2310661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Rubin SA; Chatterjee K; Ports TA; Gelberg HJ; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Nov; 44(6):1183-9. PubMed ID: 495513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Afterload reduction in the treatment of cardiac failure.
    Mason DT
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1695-703. PubMed ID: 102028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of nitroglycerin in the treatment of congestive heart failure].
    Curyło AM
    Folia Med Cracov; 1989; 30(1-2):23-9. PubMed ID: 2518363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.
    Ribner HS; Zucker MJ; Stasior C; Talentowski D; Stadnicki R; Lesch M
    Am Heart J; 1987 Jul; 114(1 Pt 1):91-6. PubMed ID: 3604877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance.
    Haber HL; Simek CL; Bergin JD; Sadun A; Gimple LW; Powers ER; Feldman MD
    J Am Coll Cardiol; 1993 Jul; 22(1):251-7. PubMed ID: 8509548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
    Brent BN; Berger HJ; Matthay RA; Mahler D; Pytlik L; Zaret BL
    Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific afterload reduction with parenteral hydralazine following cardiac surgery.
    Sladen RN; Rosenthal MH
    J Thorac Cardiovasc Surg; 1979 Aug; 78(2):195-202. PubMed ID: 459526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
    Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    Mehta J; Iacona M; Pepine CJ; Conti CR
    Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
    Priebe HJ
    Anesthesiology; 1992 May; 76(5):781-91. PubMed ID: 1575347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of nitrates in congestive heart failure.
    Cohn JN
    Am J Cardiol; 1987 Nov; 60(15):39H-43H. PubMed ID: 3120564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.